ReachMD public
[search 0]
More
Download the App!
show episodes
 
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.
  continue reading
 
ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world. Join us on the conference floor with keynote speakers, experts, and opinion leaders.
  continue reading
 
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
  continue reading
 
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer. Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest ...
  continue reading
 
Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health. So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neuro ...
  continue reading
 
Looking to digest the latest in gastroenterology? GI Insights is here to provide updates on screening guidelines, diagnostic options, and management tools for all diseases and disorders affecting the gastrointestinal tract.
  continue reading
 
Advances in Women’s Health addresses advances, breakthroughs, and treatments for conditions related to women’s health, as well as preventive measures physicians can advise their patients to pursue. Topics will include breast health as it relates to cancer, ethnicity, fertility, and pregnancy; osteoporosis; female athletes’ health and emotional issues; mental health; pregnancy and all facets related to it; aging; nutrition and health; eating disorders; alternative medicine; and sex education.
  continue reading
 
There’s a lot dermatology specialists need to consider when ensuring patients have healthy skin. And at a time when clinical research is increasingly defining skin conditions—and the practice of dermatology itself—as “more than skin deep,” turn to DermConsult. Here dermatology specialists share their expert advice on the diagnosis and treatment of a variety of skin conditions. They also explore the latest clinical research and their very own case studies, so you can rest assured you’ll have ...
  continue reading
 
Eye on Ocular Health features expert commentary on the management and prevention of debilitating eye problems, such as age-related macular degeneration, diabetic retinopathy, ocular traumas, and chronic dry eye. This series features commentary from renowned ophthalmologists discussing the most successful diagnostic and treatment options emerging in practice.
  continue reading
 
Dedicated to uncovering clinical developments and treatment advancements in the field of rheumatology, Living Rheum delivers expert insights on patient management across a broad spectrum of rheumatic diseases, such as rheumatoid arthritis, lupus, scleroderma, osteoporosis, and more.
  continue reading
 
Whenever the subject of vaccines comes up, it’s more often than not in the context of myths and controversies questioning their safety, effectiveness, and overall value. And with strong supporters on both sides of this polarizing issue, how can we as healthcare professionals ensure the health and safety of our patients? Explore this question and more on VacciNation, providing new insights on vaccines, the illnesses they prevent, and how opposing viewpoints on them can impact the world around us.
  continue reading
 
Since cardiovascular disease is one of the leading causes of death in the U.S., cardiology physicians are continuously working to better understand this common disease and to help patients improve their heart health. And here to assist cardiology physicians in this mission is Heart Matters, a series dedicated to covering essential strategies and research efforts focusing on all types of heart problems, including coronary artery diseases, heart attacks, high cholesterol, high blood pressure, ...
  continue reading
 
AudioAbstracts by ReachMD provides an easy-to-digest distillation of important medical literature in combination with digital linkage to in-depth information supporting the audio synopsis. AudioAbstracts harnesses the ReachMD digital network to broadcast the spoken synopsis and related digital links through its on-air, online, onsite, and mobile distribution network. Combining quick-read audio synopses with links to source material, AudioAbstracts is the smarter, faster way to stay current o ...
  continue reading
 
Join our hosts as they explore various genres in medical literature either for intellectual sustenance or for joy and entertainment. The ReachMD Book Club will introduce authors and topics to enliven and transform your reading experience. This series features a diverse array of medically-centered genres such as biographies and autobiographies, historicals, and contemporary fiction/non-fiction.
  continue reading
 
As the number of Americans living with diabetes continues to rise, staying up to date on the latest diabetes research is more essential than ever to help patients achieve glucose control. With Diabetes Discourse, you’ll hear from diabetes and endocrinology experts on emerging research, diagnostic and treatment strategies, and various elements that impact a patient’s disease course, including risk factors, vitamin and mineral supplementation, physical activity, and kidney disease. Because whe ...
  continue reading
 
Get to the heart of the most recent advances in lipid management and cardiovascular disease with Lipid Luminations, which features scientific and clinical research updates, novel emerging treatment options, and best practices in patient care.
  continue reading
 
Revealing Retina highlights the latest treatment advances and clinical research in retinal medicine from thought leaders in the field. This series features discussions about best practices in patient retinal care and the most recent developments in combating retinal diseases. Presented by
  continue reading
 
This innovative series provides insight into the issues experienced by advanced practice healthcare clinicians as they deliver a broad range of medical services to a diverse population, interface with other healthcare providers and navigate their own career issues. Physicians and other health care professionals will gain insights into the world of these valued partners.
  continue reading
 
Hosted by Dr. Jennifer Caudle, Everyday Family Medicine brings you the most practical and relevant updates for clinicians on the front lines of health care. With insightful topics spanning age, health, and lifestyle spectra, Everyday Family Medicine is the go-to resource for enhancing your everyday practice.
  continue reading
 
Tune in to interviews with the top thought leaders in medicine exploring the clinical and professional issues that are foremost in the minds of the medical community. Join us at the Clinician's Roundtable for discussions on a vast range of topics that every medical professional should know about.
  continue reading
 
Primary Care Today features conversations with clinical experts representing a wide range of medical specialties to highlight the latest trends in primary care practice, from clinical pearls to updated guidelines, health informatics, and practice management. This series is hosted by Dr. Brian McDonough, a nationally recognized clinical expert, teacher, and public speaker in primary care.
  continue reading
 
Lifelong Learning is a series dedicated to the history, current state, and future of medical education, where thought leaders discuss pressing issues and novel solutions related to methodology, effectiveness, funding, measurement, emerging technologies, and other aspects that make the field so vibrant. Tune in to empower your lifelong learning journey and apply new educational strategies into practice.
  continue reading
 
In The Pulse of Emergency Medicine, listeners learn about the latest information, guidelines and best practices for critical care medical professionals. Through in-depth interviews with emergency medicine experts, learn how to best serve your patients and your department.
  continue reading
 
Welcome to the ACR Action Center, bringing you the latest updates from the 2022 American College of Rheumatology (ACR) Convergence. This collection features expert insights and clinical trial data from the conference that highlights key strategies and research on rheumatic arthritis, systemic lupus erythematosus, pediatric autoimmune diseases, and more.
  continue reading
 
Two of the most undervalued words in healthcare are locum tenens, which simply means “to take the place of someone temporarily.” In other words, it refers to physicians who fill in for other doctors for one reason or another. To highlight these physicians’ inspiring journeys, Spotlight on Locum Tenens shares the ups, downs, and all-around adventures of being a locum tenens. From beginning a career on this unorthodox path to traveling overseas after retirement, these physicians have done it a ...
  continue reading
 
Welcome to the ASN Action Center, bringing you the latest updates from the 2022 American Society of Nephrology (ASN) Annual Meeting. This collection features expert insights and clinical trial data from the conference that highlights key strategies and research on diabetic kidney disease, hyperkalemia, end-stage kidney disease, and more.
  continue reading
 
Whether you're a dermatologist in Seattle, a family practitioner in New Mexico, or a trauma surgeon in New York City, the issues in health care today just can't wait. That's why you turn to ReachMD for Second Opinion Live: we're here to give you a chance to be heard.Join two of our seasoned physician hosts, Dr. Matt Birnholz and Dr. Michael Greenberg, for the next Second Opinion Live, airing on ReachMD.Do you have a topic suggestion or a story idea? Share them with us at info@reachmd.com.
  continue reading
 
This series highlights expert perspectives, key studies, and breaking news from a diverse portfolio of allergy, asthma, and immunology topics. Hosted by clinical allergists Dr. Todd Mahr and Dr. Ketan Sheth, and produced in partnership with the American College of Asthma, Allergy, and Immunology, Hot Topics in Allergy is America's go-to resource for accurate and timely AAI education.
  continue reading
 
Grand Rounds, a staple of American medical education for more than 100 years, spans every field of clinical practice. It is a master class on the art and science of medicine, delivered by renowned clinicians in academic settings nationwide. Yet in today's practice, where time is an all-too precious commodity, regular attendance at Grand Rounds sessions has become increasingly difficult. In response to this challenge, ReachMD brings the lecture hall to you, with these outstanding talks from t ...
  continue reading
 
Welcome to the Psych Congress Action Center, designed to bring you the latest updates from the annual Psych Congress meeting. This collection features the latest scientific advances, groundbreaking research presentations, and expert insights on psychopharmacology, prevalent mental health conditions, and more.
  continue reading
 
Artwork

1
SexMed

ReachMD

Unsubscribe
Unsubscribe
Monthly
 
Talking to a patient about sexual health can be as uncomfortable for the medical professional as it may be for the patient. This groundbreaking series is dedicated to helping healthcare professionals address the needs of the estimated 30-45 percent of patients who may be suffering from issues related to this under-discussed but critical aspect of patient care. SexMed presents the latest advances and current perspectives in this field, reminding us all that sexual health is integral to genera ...
  continue reading
 
Welcome to the Deep Breaths: Updates from CHEST series, dedicated to championing the prevention, diagnosis, and treatment of lung and chest diseases. Check out CHEST leaders and advocates sharing the latest in chest medicine education, clinical research, and team-based care in the areas of pulmonary diseases, critical care, and sleep medicine. Learn more about the latest diagnostic and treatment advances in pulmonology and critical care below.
  continue reading
 
This series in partnership with the American Medical Association brings healthcare professionals timely, relevant, and emerging information that impacts daily practice and the changing world of medicine. Featuring insights from health care leaders, this Perspectives with the AMA series is a must for any healthcare professional who wants to stay up to date on the latest issues and trending topics in the space, including value-based care, telehealth, the opioid epidemic, Medicare payment, cybe ...
  continue reading
 
Although we may not see tuberculosis cases too often, that doesn’t mean this disease isn’t out there. In fact, up to 13 million people are carrying the latent infection, which can asymptomatically exist in a patient for years and can be fatal if it isn’t caught early enough. That’s why knowing which of our patients are at risk and using effective screening measures are now more critical than ever. In the hopes of eradicating this disease once and for all, Tackling TB brings together experts ...
  continue reading
 
Rub Some Dirt In It takes a humorous look into the people, events, folklore, and inventions that shaped medical history. In a field pioneered by some of the greatest minds of all time, some popular ideas and practices... didn't quite cut the medical mustard. This series spotlights some of those practices that time forgot: partially to prevent history from repeating itself, partially to illuminate so-called 'primitive' approaches that actually worked, and wholly to entertain modern practition ...
  continue reading
 
Hosted by renowned dietitian Kathy King, NutritionEdge explores the latest scientific updates, sociopolitical initiatives, and controversial practice trends in nutrition and dietetics. Combining insights from Kathy King with perspectives from key experts in the field, NutritionEdge tackles important nutrition topics from a variety of standpoints such as medical genetics, chronic disease prevention, integrative medicine, psychology, and agricultural science. Ms. King, Founder and President of ...
  continue reading
 
In March 2020, the World Health Organization officially declared the SARS-COV-2 infection outbreak a global pandemic, spurring one of the greatest public health crises and education efforts in recent history. And while there have been several victories in the battle against this global pandemic, such as the widespread adoption of telehealth and the development of COVID-19 vaccines, many questions still remain. That’s why our COVID-19: On the Frontlines series features infectious disease phys ...
  continue reading
 
Loading …
show series
 
CME credits: 0.50 Valid until: 19-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/chairperson-perspective-precision-payloads-exploring-adc-directed-therapies-in-her2-mutant-and-overexpressing-lung-cancer/16609/ Alterations in ERBB2, the gene encoding HER2, have been recognized as drivers in the development of NSCLC. Therefore, HER…
  continue reading
 
Host: Joshua E. Reuss, MD Alterations in ERBB2, the gene encoding HER2, have been recognized as drivers in the development of NSCLC. Therefore, HER2 is an actionable biomarker that has emerged in NSCLC diagnosis and treatment. HER2 mutations activate the HER2 signaling pathway, which facilitates oncogenic transformation and increases tumor prolifer…
  continue reading
 
CME credits: 1.00 Valid until: 19-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/managing-treatment-related-toxicities-with-jak-inhibitor-therapy-in-myelofibrosis/26511/ Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particularly for cytopen…
  continue reading
 
CME credits: 1.00 Valid until: 19-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/improving-transfusion-independence-with-jak-inhibitor-therapy/26509/ Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particularly for cytopenic myelofibrosis, ca…
  continue reading
 
CME credits: 1.00 Valid until: 19-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/case-discussion-what-jak-inhibitor-should-i-use-in-a-transfusion-dependent-patient-with-mf-with-platelets-50-109l/26512/ Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhi…
  continue reading
 
CME credits: 1.00 Valid until: 19-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/how-and-when-to-manage-ruxolitinib-failure/26505/ Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particularly for cytopenic myelofibrosis, can significantly imp…
  continue reading
 
CME credits: 1.00 Valid until: 19-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/pacritinib-for-myelofibrosis-across-the-cytopenic-spectrum/26507/ Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particularly for cytopenic myelofibrosis, can s…
  continue reading
 
Host: Gabriela Hobbs, MD Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particularly for cytopenic myelofibrosis, can significantly improve patient outcomes. Stay informed on managing ruxolitinib intolerance and recognizing a failure to optimize therapeutic re…
  continue reading
 
Host: John Mascarenhas, MD Host: Gabriela Hobbs, MD Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particularly for cytopenic myelofibrosis, can significantly improve patient outcomes. Stay informed on managing ruxolitinib intolerance and recognizing a failure…
  continue reading
 
Host: John Mascarenhas, MD Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particularly for cytopenic myelofibrosis, can significantly improve patient outcomes. Stay informed on managing ruxolitinib intolerance and recognizing a failure to optimize therapeutic …
  continue reading
 
Host: Gabriela Hobbs, MD Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particularly for cytopenic myelofibrosis, can significantly improve patient outcomes. Stay informed on managing ruxolitinib intolerance and recognizing a failure to optimize therapeutic re…
  continue reading
 
CME credits: 1.00 Valid until: 19-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/managing-myelofibrosis-associated-anemia/26508/ Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particularly for cytopenic myelofibrosis, can significantly impro…
  continue reading
 
CME credits: 1.00 Valid until: 19-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/treatment-options-for-ruxolitinib-intolerance-or-resistance-in-myelofibrosis/26506/ Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particularly for cytopenic my…
  continue reading
 
Host: John Mascarenhas, MD Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particularly for cytopenic myelofibrosis, can significantly improve patient outcomes. Stay informed on managing ruxolitinib intolerance and recognizing a failure to optimize therapeutic …
  continue reading
 
CME credits: 1.00 Valid until: 19-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/how-to-use-prognostic-risk-scoring-and-symptom-burden-assessment-to-tailor-myelofibrosis-treatment/26504/ Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particu…
  continue reading
 
Host: John Mascarenhas, MD Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particularly for cytopenic myelofibrosis, can significantly improve patient outcomes. Stay informed on managing ruxolitinib intolerance and recognizing a failure to optimize therapeutic …
  continue reading
 
Guest: Marwan Noel Sabbagh, MD, FAAN, CCRI Autophagy through sigma-1 receptor activation is a novel mechanism of action (MOA) in development for the treatment of Alzheimer’s disease. Join Dr. Marwan Noel Sabbagh as he breaks down this new MOA and recent clinical trial data.
  continue reading
 
CME credits: 1.00 Valid until: 19-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/managing-myelofibrosis-associated-thrombocytopenia/26510/ Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particularly for cytopenic myelofibrosis, can significa…
  continue reading
 
Host: Gabriela Hobbs, MD Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particularly for cytopenic myelofibrosis, can significantly improve patient outcomes. Stay informed on managing ruxolitinib intolerance and recognizing a failure to optimize therapeutic re…
  continue reading
 
Host: John Mascarenhas, MD Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particularly for cytopenic myelofibrosis, can significantly improve patient outcomes. Stay informed on managing ruxolitinib intolerance and recognizing a failure to optimize therapeutic …
  continue reading
 
Host: Gabriela Hobbs, MD Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particularly for cytopenic myelofibrosis, can significantly improve patient outcomes. Stay informed on managing ruxolitinib intolerance and recognizing a failure to optimize therapeutic re…
  continue reading
 
Host: Jason Hafron, MD Guest: Carissa Chu. MD Despite treatment advances in genitourinary cancers, most patients will develop relapsed disease. Thus, new treatment approaches are needed, as well as improved methods to identify patients who will derive the optimal benefit from established and emerging therapies. Real-world data provide crucial insig…
  continue reading
 
CME credits: 0.50 Valid until: 18-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/advancements-in-gu-cancers-key-data-from-aua-2024/24417/ Despite treatment advances in genitourinary cancers, most patients will develop relapsed disease. Thus, new treatment approaches are needed, as well as improved methods to identify patients who…
  continue reading
 
CME credits: 1.00 Valid until: 17-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/empowering-treatment-choice-the-essential-role-of-shared-decision-making-in-unresectable-hcc/26338/ This online MinuteCE program provides a comprehensive evaluation of the latest clinical data on first-line immune checkpoint inhibitor (ICI) combinati…
  continue reading
 
CME credits: 1.00 Valid until: 17-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/selecting-the-optimal-ici-partner-for-first-line-treatment-of-unresectable-hcc-ctla-4-vs-vegf-inhibitors/26332/ This online MinuteCE program provides a comprehensive evaluation of the latest clinical data on first-line immune checkpoint inhibitor (IC…
  continue reading
 
CME credits: 1.00 Valid until: 17-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/emerging-first-line-ici-combination-regimens-in-patients-with-unresectable-hcc/26334/ This online MinuteCE program provides a comprehensive evaluation of the latest clinical data on first-line immune checkpoint inhibitor (ICI) combinations for the tr…
  continue reading
 
CME credits: 1.00 Valid until: 17-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/use-of-ici-combination-regimens-in-patients-with-intermediate-stage-hcc/26333/ This online MinuteCE program provides a comprehensive evaluation of the latest clinical data on first-line immune checkpoint inhibitor (ICI) combinations for the treatment…
  continue reading
 
CME credits: 1.00 Valid until: 17-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/current-unmet-needs-in-the-field-of-unresectable-hcc/26329/ This online MinuteCE program provides a comprehensive evaluation of the latest clinical data on first-line immune checkpoint inhibitor (ICI) combinations for the treatment of unresectable he…
  continue reading
 
Host: Ghassan K. Abou-Alfa, MD Guest: Aiwu Ruth He, MD, PhD This online MinuteCE program provides a comprehensive evaluation of the latest clinical data on first-line immune checkpoint inhibitor (ICI) combinations for the treatment of unresectable hepatocellular carcinoma (HCC). Participants will critically assess survival outcomes and other key ef…
  continue reading
 
CME credits: 1.00 Valid until: 17-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/enhancing-outcomes-in-unresectable-hcc-through-integrated-multidisciplinary-care-models/26337/ This online MinuteCE program provides a comprehensive evaluation of the latest clinical data on first-line immune checkpoint inhibitor (ICI) combinations f…
  continue reading
 
CME credits: 1.00 Valid until: 17-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/case-consult-treatment-options-for-an-unresectable-hcc-patient-who-has-esophageal-varices/26335/ This online MinuteCE program provides a comprehensive evaluation of the latest clinical data on first-line immune checkpoint inhibitor (ICI) combinations…
  continue reading
 
Host: Patrick Forde, M.B.B.Ch. Guest: Jarushka Naidoo, MBBCh, MHS Struggling to navigate the latest immunotherapy options for advanced NSCLC? This online CME program delves into optimizing dual immune checkpoint inhibitor therapy for patients with driver-negative advanced NSCLC. Learn how to leverage recent clinical trial data and patient character…
  continue reading
 
Host: Ghassan K. Abou-Alfa, MD Guest: Aiwu Ruth He, MD, PhD This online MinuteCE program provides a comprehensive evaluation of the latest clinical data on first-line immune checkpoint inhibitor (ICI) combinations for the treatment of unresectable hepatocellular carcinoma (HCC). Participants will critically assess survival outcomes and other key ef…
  continue reading
 
Host: Ghassan K. Abou-Alfa, MD This online MinuteCE program provides a comprehensive evaluation of the latest clinical data on first-line immune checkpoint inhibitor (ICI) combinations for the treatment of unresectable hepatocellular carcinoma (HCC). Participants will critically assess survival outcomes and other key efficacy metrics from recent st…
  continue reading
 
CME credits: 1.00 Valid until: 17-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/pivotal-data-supporting-first-line-durvalumabtremelimumab-in-unresectable-hcc/26330/ This online MinuteCE program provides a comprehensive evaluation of the latest clinical data on first-line immune checkpoint inhibitor (ICI) combinations for the tre…
  continue reading
 
CME credits: 1.50 Valid until: 17-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/case-by-case-optimizing-dual-immune-checkpoint-inhibitor-combination-therapies-in-advanced-driver-negative-nonsmall-cell-lung-cancer/24418/ Struggling to navigate the latest immunotherapy options for advanced NSCLC? This online CME program delves int…
  continue reading
 
CME credits: 1.00 Valid until: 17-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/pivotal-data-supporting-first-line-atezolizumabbevacizumab-in-unresectable-hcc/26331/ This online MinuteCE program provides a comprehensive evaluation of the latest clinical data on first-line immune checkpoint inhibitor (ICI) combinations for the tr…
  continue reading
 
Loading …

Quick Reference Guide